The evidence behind physical activity as a therapeutic intervention is stronger than most people realise. Here is the dose, the mechanism, and your personal prescription.
By Dr. Joseph Ntiamoah (PT) | Consultant Physiotherapist & Neurorehabilitation Specialist
The Rehab Haven Rehabilitation Centre | Kumasi, Ghana | ptntiamoah.com | 0532767597
I want to begin with a statement that is unusual coming from a healthcare professional, because it sounds like hyperbole but is supported by an evidence base as strong as anything in pharmacology: if physical exercise could be packaged as a drug, it would be the most prescribed, most profitable, and most transformative pharmaceutical in medical history.
This is not motivational rhetoric. It is a conclusion that follows directly from the meta-analytic literature on physical activity and health outcomes. The evidence for exercise as a preventive and therapeutic intervention spans cardiovascular health, metabolic disease, mental health, neurological function, musculoskeletal integrity, cancer prevention, and cognitive performance — and in most of these domains, the effect sizes rival or exceed those of the best pharmacological agents available.
In Ghana, where cardiovascular disease, stroke, diabetes, and depression are rising rapidly as urbanisation proceeds, and where healthcare access for chronic disease management is inadequate to the scale of need, exercise is not a supplementary recommendation. It is a primary clinical intervention that every Ghanaian adult should be prescribed and educated about as systematically as any medication.
The Evidence — What Exercise Actually Does
Cardiovascular and Stroke Prevention
Aerobic exercise at 150 minutes per week (30 minutes, 5 days) reduces systolic blood pressure by 5 to 8 mmHg — clinically equivalent to mild antihypertensive pharmacotherapy. It reduces stroke risk by 27 percent, cardiovascular mortality by 35 percent, and all-cause mortality by 35 percent. These are not marginal effects. They are among the largest effect sizes produced by any preventive intervention in medicine.
The mechanisms are multiple: improved endothelial function, reduced arterial stiffness, enhanced cardiac stroke volume, reduced resting heart rate, and systemic anti-inflammatory effects — all operating simultaneously through a single intervention.
Metabolic Disease Prevention and Reversal
The Diabetes Prevention Programme — one of the most important lifestyle medicine trials ever conducted — found that a combination of 7 percent body weight reduction and 150 minutes of weekly physical activity reduced progression from pre-diabetes to type 2 diabetes by 58 percent. Metformin, the standard pharmacological intervention for pre-diabetes, produced a 31 percent reduction. Lifestyle intervention outperformed medication.
For people with established type 2 diabetes: regular aerobic exercise activates GLUT-4 transporters in skeletal muscle, improving glucose uptake independent of insulin — a mechanism that medication cannot replicate. Exercise also improves insulin sensitivity systemically, reduces HbA1c, and reduces cardiovascular risk — the primary cause of death in diabetic patients.
Mental Health
A meta-analysis of 35 randomised controlled trials found that exercise produces antidepressant effects equivalent to medication in mild-to-moderate depression, without the side effects, withdrawal effects, or cost of pharmacotherapy. The mechanisms are neurobiological: exercise increases serotonin and dopamine synthesis and release, elevates BDNF (the brain's primary growth and maintenance protein), reduces cortisol and HPA axis reactivity, improves sleep architecture, and builds self-efficacy.
Brain Health and Dementia Prevention
Regular aerobic exercise increases hippocampal volume — the brain's primary memory structure — and delays dementia onset by 7 to 10 years in active versus sedentary individuals. BDNF, released during aerobic exercise, supports neuronal survival, synaptic plasticity, and neurogenesis. Exercise is the most accessible neuroprotective intervention available — and it is free.
The Dose: How Much Exercise Do You Actually Need?
The most important finding for people who currently do no exercise is this: any increase from zero activity produces significant mortality benefit. A meta-analysis of over one million participants found that the steepest dose-response reduction in mortality risk occurs in moving from no activity to 75 minutes per week — half the guideline minimum. The first 15 minutes you walk tomorrow morning is the most medically significant exercise session you will ever do.
The Ghanaian Context: Why Exercise Adoption Is Challenging — and How to Overcome It
Cultural Barriers
In Ghana's formal professional culture, exercise is frequently perceived as inconsistent with serious professional identity — associated with physical labour or recreational pursuit rather than professional performance. Changing this cultural framing — positioning physical activity as foundational to cognitive function, professional productivity, and career longevity — is a prerequisite for sustainable adoption in this demographic.
Time Barriers
The most common barrier to exercise reported by Ghanaian professionals is time. The evidence-based response: 150 minutes per week is 2.2 percent of the total available weekly hours. Walking meetings replace sedentary meetings with no net time cost. Morning walking (before the working day begins) is resistant to schedule displacement. The 15-minute daily walk is achievable by virtually every working adult regardless of schedule.
Practical Starting Points for the Ghanaian Professional
Start with walking. No gym. No equipment. No schedule disruption. 15 minutes tomorrow morning. Build to 30 minutes. Add a second session. The biological reality: starting from complete sedentary baseline, the first small steps produce the greatest relative mortality benefit available. The perfect exercise programme that never starts produces zero benefit. The imperfect one that happens every morning produces enormous benefit.
───────────────────────────────────────────────────
About the Author
Dr. Joseph Ntiamoah (PT) is a Consultant Physiotherapist and Neurorehabilitation Specialist and the Founder of The Rehab Haven Rehabilitation Centre, Kumasi, Ghana. He specialises in stroke rehabilitation, neurological rehabilitation, homecare physiotherapy, and preventive health education. He is the author of Stroke Before 50, Exercise as Medicine, and Daily Mobility for Office Workers.
For consultations, home rehabilitation referrals, or corporate wellness enquiries: 0532767597 | ptntiamoah.com
Watch explainer here: The Sitting Disease: Why Your Desk Job is a Stroke Risk (and How to Fix)
